Global Hereditary Angioedema Therapeutic Market Research Report 2025(Status and Outlook)

March 2025 | 210 pages | ID: GD66CE7C0234EN
Bosson Research

Abstracts

Report Overview

Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.

This report provides a deep insight into the global Hereditary Angioedema Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Therapeutic market in any manner.

Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BioCryst Pharma

Ionis Pharma

Pharming Group

CSL Limited

Shire

Attune Pharma

Adverum Biotechnologies

KalVista Pharma

Market Segmentation (by Type)

Intravenous

Subcutaneous

Oral

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hereditary Angioedema Therapeutic Market
• Overview of the regional outlook of the Hereditary Angioedema Therapeutic Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Hereditary Angioedema Therapeutic Market Overview
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Hereditary Angioedema Therapeutic Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Therapeutic Product Life Cycle
3.3 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Hereditary Angioedema Therapeutic Manufacturing Sites, Area Served, Product Type
3.8 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hereditary Angioedema Therapeutic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Hereditary Angioedema Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 Global Hereditary Angioedema Therapeutic Market by Region
6.1 Global Hereditary Angioedema Therapeutic Market Size by Region
6.1.1 Global Hereditary Angioedema Therapeutic Market Size by Region
6.1.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Region
6.2 Global Hereditary Angioedema Therapeutic Sales by Region
6.2.1 Global Hereditary Angioedema Therapeutic Sales by Region
6.2.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
7 North America Market Overview
7.1 North America Hereditary Angioedema Therapeutic Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Hereditary Angioedema Therapeutic Market Size by Type
7.3 North America Hereditary Angioedema Therapeutic Market Size by Application
8 Europe Market Overview
8.1 Europe Hereditary Angioedema Therapeutic Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Hereditary Angioedema Therapeutic Market Size by Type
8.3 Europe Hereditary Angioedema Therapeutic Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type
9.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application
10 South America Market Overview
10.1 South America Hereditary Angioedema Therapeutic Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Hereditary Angioedema Therapeutic Market Size by Type
10.3 South America Hereditary Angioedema Therapeutic Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Type
11.3 Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Application
12 Hereditary Angioedema Therapeutic Market Production by Region
12.1 Global Production of Hereditary Angioedema Therapeutic by Region(2020-2025)
12.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
12.3 Global Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Hereditary Angioedema Therapeutic Production
12.4.1 North America Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
12.4.2 North America Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Hereditary Angioedema Therapeutic Production
12.5.1 Europe Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
12.5.2 Europe Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Hereditary Angioedema Therapeutic Production (2020-2025)
12.6.1 Japan Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
12.6.2 Japan Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Hereditary Angioedema Therapeutic Production (2020-2025)
12.7.1 China Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
12.7.2 China Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
13 Hereditary Angioedema Therapeutic Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2033)
13.3 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2020-2033)
13.4 Global Hereditary Angioedema Therapeutic Price by Type (2020-2033)
14 Hereditary Angioedema Therapeutic Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2020-2033)
14.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2033)
14.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 BioCryst Pharma
15.1.1 BioCryst Pharma Basic Information
15.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
15.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
15.1.4 BioCryst Pharma Business Overview
15.1.5 BioCryst Pharma SWOT Analysis
15.1.6 BioCryst Pharma Recent Developments
15.2 Ionis Pharma
15.2.1 Ionis Pharma Basic Information
15.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
15.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
15.2.4 Ionis Pharma Business Overview
15.2.5 Ionis Pharma SWOT Analysis
15.2.6 Ionis Pharma Recent Developments
15.3 Pharming Group
15.3.1 Pharming Group Basic Information
15.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
15.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
15.3.4 Pharming Group Business Overview
15.3.5 Pharming Group SWOT Analysis
15.3.6 Pharming Group Recent Developments
15.4 CSL Limited
15.4.1 CSL Limited Basic Information
15.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
15.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
15.4.4 CSL Limited Business Overview
15.4.5 CSL Limited Recent Developments
15.5 Shire
15.5.1 Shire Basic Information
15.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
15.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
15.5.4 Shire Business Overview
15.5.5 Shire Recent Developments
15.6 Attune Pharma
15.6.1 Attune Pharma Basic Information
15.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
15.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
15.6.4 Attune Pharma Business Overview
15.6.5 Attune Pharma Recent Developments
15.7 Adverum Biotechnologies
15.7.1 Adverum Biotechnologies Basic Information
15.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
15.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
15.7.4 Adverum Biotechnologies Business Overview
15.7.5 Adverum Biotechnologies Recent Developments
15.8 KalVista Pharma
15.8.1 KalVista Pharma Basic Information
15.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
15.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
15.8.4 KalVista Pharma Business Overview
15.8.5 KalVista Pharma Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 5. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2024)
Table 11. Global Market Hereditary Angioedema Therapeutic Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Hereditary Angioedema Therapeutic Manufacturing Sites and Area Served
Table 13. Manufacturers Hereditary Angioedema Therapeutic Product Type
Table 14. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 26. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2033) & (M USD)
Table 27. Global Hereditary Angioedema Therapeutic Market Size Market Share by Region (2020-2033)
Table 28. Global Hereditary Angioedema Therapeutic Sales by Region (2020-2033) & (K MT)
Table 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2033)
Table 30. North America Hereditary Angioedema Therapeutic Market Size by Country (2020-2033) & (M USD)
Table 31. North America Hereditary Angioedema Therapeutic Sales by Country (2020-2033) & (K MT)
Table 32. North America Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 33. North America Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 34. North America Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 35. North America Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2033)
Table 36. North America Hereditary Angioedema Therapeutic Sales by Application (K MT)
Table 37. North America Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 38. North America Hereditary Angioedema Therapeutic Sales (K MT) by Application (2020-2033)
Table 39. North America Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2033)
Table 40. Europe Hereditary Angioedema Therapeutic Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Hereditary Angioedema Therapeutic Sales by Country (2020-2033) & (K MT)
Table 42. Europe Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 43. Europe Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 44. Europe Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 45. Europe Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2033)
Table 46. Europe Hereditary Angioedema Therapeutic Sales by Application (K MT)
Table 47. Europe Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 48. Europe Hereditary Angioedema Therapeutic Sales (K MT) by Application (2020-2033)
Table 49. Europe Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 53. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 54. Asia-Pacific Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Hereditary Angioedema Therapeutic Sales by Application (K MT)
Table 57. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 58. Asia-Pacific Hereditary Angioedema Therapeutic Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2025)
Table 60. South America Hereditary Angioedema Therapeutic Market Size by Country (2020-2033) & (M USD)
Table 61. South America Hereditary Angioedema Therapeutic Sales by Country (2020-2033) & (K MT)
Table 62. South America Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 63. South America Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 64. South America Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 65. South America Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2033)
Table 66. South America Hereditary Angioedema Therapeutic Sales by Application (K MT)
Table 67. South America Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 68. South America Hereditary Angioedema Therapeutic Sales (K MT) by Application (2020-2033)
Table 69. South America Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 73. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 74. Middle East and Africa Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Application (K MT)
Table 77. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Application (M USD)
Table 78. Middle East and Africa Hereditary Angioedema Therapeutic Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2033)
Table 80. Global Hereditary Angioedema Therapeutic Production (K MT) by Region(2020-2025)
Table 81. Global Hereditary Angioedema Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
Table 83. Global Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 89. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 90. Global Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2033)
Table 91. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2033)
Table 92. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2033)
Table 93. Global Hereditary Angioedema Therapeutic Market Size Share by Type (2020-2033)
Table 94. Global Hereditary Angioedema Therapeutic Sales (K MT) by Application
Table 95. Global Hereditary Angioedema Therapeutic Market Size by Application(M USD)
Table 96. Global Hereditary Angioedema Therapeutic Sales by Application (2020-2033) & (K MT)
Table 97. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2033)
Table 98. Global Hereditary Angioedema Therapeutic Market Size by Application (2020-2033) & (M USD)
Table 99. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2033)
Table 100. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2033)
Table 101. BioCryst Pharma Basic Information
Table 102. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 103. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. BioCryst Pharma Business Overview
Table 105. BioCryst Pharma SWOT Analysis
Table 106. BioCryst Pharma Recent Developments
Table 107. Ionis Pharma Basic Information
Table 108. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 109. Ionis Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Ionis Pharma Business Overview
Table 111. Ionis Pharma SWOT Analysis
Table 112. Ionis Pharma Recent Developments
Table 113. Pharming Group Basic Information
Table 114. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 115. Pharming Group Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Pharming Group Business Overview
Table 117. Pharming Group SWOT Analysis
Table 118. Pharming Group Recent Developments
Table 119. CSL Limited Basic Information
Table 120. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 121. CSL Limited Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. CSL Limited Business Overview
Table 123. CSL Limited Recent Developments
Table 124. Shire Basic Information
Table 125. Shire Hereditary Angioedema Therapeutic Product Overview
Table 126. Shire Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Shire Business Overview
Table 128. Shire Recent Developments
Table 129. Attune Pharma Basic Information
Table 130. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 131. Attune Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Attune Pharma Business Overview
Table 133. Attune Pharma Recent Developments
Table 134. Adverum Biotechnologies Basic Information
Table 135. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 136. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Adverum Biotechnologies Business Overview
Table 138. Adverum Biotechnologies Recent Developments
Table 139. KalVista Pharma Basic Information
Table 140. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 141. KalVista Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. KalVista Pharma Business Overview
Table 143. KalVista Pharma Recent Developments
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2024-2033
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2020-2033)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Therapeutic Product Life Cycle
Figure 13. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2024
Figure 14. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2024
Figure 15. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hereditary Angioedema Therapeutic Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2024
Figure 18. Industry Chain Map of Hereditary Angioedema Therapeutic
Figure 19. Global Hereditary Angioedema Therapeutic Market PEST Analysis
Figure 20. Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Hereditary Angioedema Therapeutic Market Size by Region
Figure 27. Global Hereditary Angioedema Therapeutic Market Size Market Share by Region (2020-2033)
Figure 28. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Hereditary Angioedema Therapeutic Market Size (M USD) by Country
Figure 33. USA Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Hereditary Angioedema Therapeutic Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Hereditary Angioedema Therapeutic Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Hereditary Angioedema Therapeutic Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Hereditary Angioedema Therapeutic Market Size (M USD)by Type
Figure 40. North America Hereditary Angioedema Therapeutic Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Hereditary Angioedema Therapeutic Market Size (M USD) by Country
Figure 45. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Hereditary Angioedema Therapeutic Market Size (M USD) by Type
Figure 56. Europe Hereditary Angioedema Therapeutic Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Hereditary Angioedema Therapeutic Market Size (M USD) by Country
Figure 61. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Hereditary Angioedema Therapeutic Market Size (M USD) by Type
Figure 72. Asia-Pacific Hereditary Angioedema Therapeutic Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Hereditary Angioedema Therapeutic Market Size (M USD) by Country
Figure 77. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Hereditary Angioedema Therapeutic Market Size (M USD) by Type
Figure 84. South America Hereditary Angioedema Therapeutic Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Therapeutic Market Size (M USD) by Country
Figure 89. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Hereditary Angioedema Therapeutic Market Size (M USD) by Type
Figure 100. Middle East and Africa Hereditary Angioedema Therapeutic Market Size (M USD) by Application
Figure 101. Global Hereditary Angioedema Therapeutic Production Market Share by Region (2020-2025)
Figure 102. North America Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. China Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Figure 108. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2020-2033)
Figure 109. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2024
Figure 110. Market Size Share of Hereditary Angioedema Therapeutic by Type (2020-2033)
Figure 111. Market Size Share of Hereditary Angioedema Therapeutic by Type in 2024
Figure 112. Global Hereditary Angioedema Therapeutic Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Hereditary Angioedema Therapeutic Market Size by Application(M USD)
Figure 115. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 116. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2033)
Figure 117. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2024
Figure 118. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2033)
Figure 119. Global Hereditary Angioedema Therapeutic Market Share by Application in 2024
Figure 120. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2033)